ArticlePDF Available

Folate Deficiency Triggered Apoptosis of Synoviocytes: Role of Overproduction of Reactive Oxygen Species Generated via NADPH Oxidase/Mitochondrial Complex II and Calcium Perturbation

PLOS
PLOS ONE
Authors:

Abstract and Figures

Despite a plethora of literature has documented that osteoarthritis (OA) is veritably associated with oxidative stress-mediated chondrocyte death and matrix degradation, yet the possible involvement of synoviocyte abnormality as causative factor of OA has not been thoroughly investigated. For this reason, we conduct the current studies to insight into how synoviocytes could respond to an episode of folate-deprived (FD) condition. First, when HIG-82 synoviocytes were cultivated under FD condition, a time-dependent growth impediment was observed and the demise of these cells was demonstrated to be apoptotic in nature mediated through FD-evoked overproduction of reactive oxygen species (ROS) and drastically released of cytosolic calcium (Ca2+) concentrations. Next, we uncovered that FD-evoked ROS overproduction could only be strongly suppressed by either mitochondrial complex II inhibitors (TTFA and carboxin) or NADPH oxidase (NOX) inhibitors (AEBSF and apocynin), but not by mitochondrial complex I inhibitor (rotenone) and mitochondrial complex III inhibitor (antimycin A). Interestingly, this selective inhibition of FD-evoked ROS by mitochondrial complex II and NOX inhibitors was found to correlate excellently with the suppression of cytosolic Ca2+ release and reduced the magnitude of the apoptotic TUNEL-positive cells. Taken together, we present the first evidence here that FD-triggered ROS overproduction in synoviocytes is originated from mitochondrial complex II and NOX. Both elevated ROS in tandem with cytosolic Ca2+ overload serve as final arbitrators for apoptotic lethality of synoviocytes cultivated under FD condition. Thus, folate supplementation may be beneficial to patients with OA.
Folate deficiency impedes the growth of synoviocytes. (A) HIG-82 synoviocytes (3×104) or (B) HIG-82 synoviocytes (3×105) were plated in 12-well culture plates or 100-mm cultured dishes, respectively, for 24 h. The culture medium was replaced with three types of media: (1) Control F12 culture medium containing folate supplemented with 10% undialyzed fetal bovine serum (FBS), designated as FC medium. (2) Marginal folate deficient medium containing folate, but supplemented with dialyzed FBS (dFBS), designated as MFD medium. (3) Folated deficient medium containing no folate, thymidine, hypoxanthine, glycine and supplemented with 10% of dFBS, designated as FD medium. Other experimental groups were MFD plus 1 μM folate (FA) and FD plus 1 μM folate. (A) Synoviocytes cultivated with these types of media were allowed to grow for 1, 2 and 3 days. The viability of the cells was then determined by MTT assay. (B) Synoviocytes cultivated with FC, MFD, and FD media and allowed to grow for 48 h. The concentrations of folate in media and cells were evaluated by HPLC. Illustrate chromatograms of the folate studied the analyzed cell lysed samples (FC, FD, and MFD medium). The retention time for folate was tR 15.8 ± 0.2 min. LC C-18 column 5 μm (250 mm × 4.6 mm) and a mobile phase, consisting of 40 mM sodium phosphate dibasic, heptahydrate buffer, and 5% acetonitrile (v/v), pH 5.5. The values shown are expressed as mean ± SD (n = 5–8 samples per experiment). Significant differences from the FC group are p<0.05 (*), p<0.01 (**), p<0.001 (***).
… 
Folate deficiency provokes apoptotic lethality in synoviocytes. HIG-82 synoviocytes (1.5×105) were plated in 60-mm cultured dishes for 24 h. The culture medium was replaced with FC, MFD, and FD media and then continued cultivating for additional 48 h. (A) Cells were then collected, washed with PBS, fixed in PBS-methanol (1:2 v/v) solution and maintained at 4°C for at least 18 h. After one washed with PBS, the cell pellets were then stained with a PI solution containing PBS, PI (40μg/mL), and DNase-free RNase A (40μg/mL) for 30 min at RT in the dark. The cell pellets were then analyzed using a Becton-Dickinson FACSan flowcytometer. The epirubicin (500 nM) treatment (Epi) is a positive control assay of apoptosis. The blank bar, gray bar, right slash bar and left slash bar represent FC, MFD, FD and Epi treatment, respectively. The percentages of subG1 population determined by the PI fluorescent intensity in apoptosis cells which was weaker than that of cells in the G1 phase. The percentages of apoptosis cells were characterized as the percentages of cells in the SubG1 region of the DNA distribution histograms. The FD subG1 bar graph is compared with FC or MFD. A p<0.05 (*) was considered statistically significant. (B) Cells were fixed in 1% paraformaldehyde in PBS for 30 min, then washed with PBS, and stored in 70% methanol at 4°C. After rehydration in PBS, cells were evaluated with TUNEL assay. The values shown are mean ± SD (n = 5–8 samples per experiment). Significant differences from the FC or MFD groups are p<0.05 (*), p<0.01 (**), p<0.001 (***).
… 
Content may be subject to copyright.
RESEARCH ARTICLE
Folate Deficiency Triggered Apoptosis of
Synoviocytes: Role of Overproduction of
Reactive Oxygen Species Generated via
NADPH Oxidase/Mitochondrial Complex II
and Calcium Perturbation
Hung-Chih Hsu
1,2,3,4
, Wen-Ming Chang
1,2
, Jin-Yi Wu
5
, Chin-Chin Huang
5
, Fung-Jou Lu
6
,
Yi-Wen Chuang
1,2
, Pey-Jium Chang
3
, Kai-Hua Chen
1,2
, Chang-Zern Hong
7
, Rang-Hui Yeh
1
,
Tsan-Zon Liu
8
*, Ching-Hsein Chen
5
*
1 Department of Physical Medicine and Rehabilitation, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi,
Taiwan, 2 Department of Nursing, Chang-Gung University of Science and Technology, Chia-Yi, Taiwan,
3 Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan,
Taiwan, 4 Center of Advanced Integrative Sports Medicine, Chia-Yi Chang Gung Memorial Hospital, Chia-
Yi, Taiwan, 5 Department of Microbiology, Immunology and Biopharmaceuticals, Collage of Life Sciences,
National Chiayi University, Chiayi City 60004, Taiwan, 6 Institute of Medicine, Chung Shan Medical
University, Taichung, Taiwan, 7 Department of Physical therapy, Hung Kuang University, Taichung,
Taiwan, 8 Translational Research Laboratory, Cancer Center, Taipei Medical University and Hospital,
Taipei, Taiwan
These authors contributed equally to this work.
* tzliu@tmuh.org.tw (TZL); chench@mail.ncyu.edu.tw (CHC)
Abstract
Despite a plethora of literature has documented that osteoarthri tis (OA) is veritably associ-
ated with oxidative stress-mediated chondrocyte death and matr ix degradation, yet the pos-
sible involvement of synoviocyte abnormality as causative factor of OA has not been
thoroughly investigated. For this reason , we conduct the current studies to insight into how
synoviocytes could respond to an episode of folate-deprived (FD) condition. First, when
HIG-82 synoviocytes were cultivated under FD condition, a time-dependent growth impedi-
ment was observed and the demise of these cells was demonstrated to be apoptotic in
nature mediated through FD-evoked overproduction of reactive oxygen species (ROS) and
drastically released of cytosolic calcium (Ca
2+
) concentrations. Next, we uncove red that
FD-evoked ROS overproduction could only be strongly suppressed by either mitochondrial
complex II inhibitors (TTFA and carboxin) or NADPH oxidase (NOX) inhibitors (AEBS F and
apocynin), but not by mitochondrial complex I inhibitor (rotenone) and mitochondrial com-
plex III inhibitor (antimycin A). Interestingly, this selective inhibition of FD-evoked ROS by
mitochondrial complex II and NOX inhibitors was found to correlate excellently with the sup-
pression of cytosolic Ca
2+
release and reduced the magnitude of the apoptotic TUNEL-posi-
tive cells. Taken together, we present the first evidence here that FD-triggered ROS
overproduction in synoviocytes is originated from mitochondrial complex II and NOX. Both
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 1/21
a11111
OPEN ACCESS
Citation: Hsu H-C, Chang W-M, Wu J-Y, Huang C-C,
Lu F-J, Chuang Y-W, et al. (2016) Folate Deficiency
Triggered Apoptosis of Synoviocytes: Role of
Overproduction of Reactive Oxygen Species
Generated via NADPH Oxidase/Mitochondrial
Complex II and Calcium Perturbation. PLoS ONE
11(1): e0146440. doi:10.1371/journal.pone.0146440
Editor: Brij Singh, School of Medicine and Health
Sciences, University of North Dakota, UNITED
STATES
Received: March 6, 2015
Accepted: December 17, 2015
Published: January 15, 2016
Copyright: © 2016 Hsu et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This study was supported by Chang Gung
Memorial Hospital, R.O.C. (CMRPG6B0471, W.M.C.)
and in part by National Science Council, Taiwan
(NSC 102-2320-B-415-005-MY3; National Science
Councils, C.H.C.). The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
elevated ROS in tandem with cytosolic Ca
2+
overload serve as final arbitrators for apoptotic
lethality of synoviocytes cultivated under FD condition. Thus, folate supplementation may
be beneficial to patients with OA.
Introduction
Osteoarthritis (OA) is a time- and age-dependent process leading to aberrant cartilage struc-
ture which is characterized by decreased number of chondrocytes, deterioration of existing car-
tilage extracellular matrix, and abnorma lity in composition and pathologic matrix calcification
[1].
Cellular redox homeostasis is maintained by the balance between reactive oxygen species
(ROS) generation and elimination. However, when this balance is tilted in favor of the state of
increased ROS generation is referred to as oxidative stress. Despite oxidative stress has been
incriminated as causative factor in the pathogenesis of OA [2,3], yet, the involvement of syno-
viocyte functional abnormality as a possible contributing factor of OA has not previously been
investigated.
Folic acid (folate; vitamin B9) is an essential micronutrient which serves as critical coen-
zymes for purine and thymidylate biosynthesis and biological methylation of macromolecules
and remethylation of homocysteine (Hcy) back to methionine [4,5,6]. A plethora of literature
has documented that folate deficiency (FD) could trigger ROS overproduction and intracellular
calcium overloading leading to the occurrence of apoptosis in many cell types [7,8,9,10,11]. In
addition, FD-instigated oxdative stress has been directly or indirectly involved in the pathogen-
esis of many diseases such as cardiovascular diseases, anemia, fetus neural tube defect, cancer,
Alzheimers disease [7,12,13,14,15,16,17,18,19]. Thus, FD-induced oxidative stress could be
constituted as one of the risk factors for a variety of diseases.
FD may occur at all ages, particularly in persons ingesting a poor diet or suffering from
intestinal malabsorption or who have excessive alcohol intake [20]. Clarke et al. [21] reported
that the prevalence of FD increase with age which was correlated excellently with the occur-
rence of OA in the elderly population, which will create a major health care challenge and
places an enormous economic burden on society [22].
FD can predominantly trigger oxidative stress-mediated accumulation of Hcy, the latter is
known to modulate bone remodeling through several known mechanisms such as increasing
in osteoclast activity in tandem with decreasing osteoclast function and direct action of Hcy on
bone matrix. These observed effects were demonstrated to be ascribable to the activation of
metalloproteinases (MMPs) that degrade extracellular bone matrix [23]. Furthermore, the
underlying mechanism associated with this observed phenomenon was probably attributed to
the activation of NF-κ B via Hcy-instigated H
2
O
2
production as analogous to the literature
reported elsewhere [24]. Along the same vein, FD was previously demonstrated to activate
inducible NO synthase (iNOS) resulting in NO-mediated nitrosative stress [7]. Interestingly,
NO has been shown to impede chondrocyte survival and induces cell death [1]. All in all, these
reports highlight the important of FD in the acquisition of apoptosis in chondrocytes. How-
ever, information pertaining to the effects of FD on the functional attributes of synoviocytes
and its possible involvement in the pathogenesis of OA is spares. For this reason, this study will
focus on the aspect of FD in the survival of synoviocytes, and the role of ROS and to identify
the originating sites of mitochondrial respiratory chain (MRC) using various site specific
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 2/21
Competing Interests: The authors have declared
that no competing interests exist.
inhibitors targeting various complexes localized in MRC. Unrevealing the underlying mecha-
nism(s) of cell demise by FD are also within the scope of this investigation.
Materials and Methods
Cell line and reagents
HIG-82 cell line (rabbit synoviocytes) and HeLa cell line were obtained from the Bioresource
Collection and Research Center (Hsinchu, Taiwan). The folate deficient medium powder used
in this study was purchased from GIBCO for which folate as well as thymidine, hypoxanthine,
and glycine were omitted from complete media to stress substrate availability in one carbon
metabolism. To minimize exogenous fola te source, fetal bovine serum was replaced with dia-
lyzed fetal bovine serum (dFBS). Control medium was complete medium with 10% FBS.
Dichlorofluorescein diacetate (DCFH-DA) and chloromethylflourescein diacetate (CMF-DA)
were acquired from Invitrogen Co. (Carlsbad, CA). FITC-IETD-FMK and FITC-LEHD-FMK
were obtained from United States Biological (Swampscott, MA). The primary antibodies
against caspase 3, gp91, p22 and second antibodies were obtained from Santa Cruz Biotechnol-
ogy, Inc., (Santa Cruz, CA). The primary antibodies against β-actin, JC-1, Fluo 3-AM and
other chemicals were purchased from Sigma Che mical Co. (St. Louis, MO).
Cell culture and treatment
HIG-82 synoviocytes (1×10
6
) were cultured in an F-12 medium supplemented with 10% fetal
bovine serum, 100 U/ml penicillin and 100 lg/ml streptomycin in 100-mm cultured dishes at
37°C in a humidified atmosphere of 5% CO
2
. HeLa cells (1×10
6
) were cultured in a DMEM/F-
12 1:1 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 lg/ml
streptomycin in 100-mm cultured dishes at 37°C in a humidified atmosphere of 5% CO
2
.
When cells reach 80% confluence in 100-mm cultured dishes, the cells were washed with PBS
and trypsinized to use in various experiments. The selective inhibitors and its particular con-
centrations used to inhibit the intracellular ROS generation from various enzymes were refer-
enced and modified from our previous publication [25]. These particular concentrations of
selective inhibitors did not affect the cell viability of HIG-82 cells. The selective inhibitor of
mitochondrial complex I (rotenone 20 nM), mitochondrial complex II (carboxin 5 μMor
TTFA 5 μM), mitochondrial complex III (antimycin A 0.01 nM) and NADPH oxidase (AEBSF
2 μM or apopcynin 30 μM) were pretreated 2 h, followed by FD treatment for 48 h. Calcium
chelator (BAPTA 5 μM) was pretreated 3 h, followed by FD treatment for 48 h. These inhibi-
tors were purchased form Sigma Chemical Co. (St. Louis, MO).
Cell viability assay
Cell viability was assessed by the MTT assay. The MTT (Sigma-Aldrich, St. Louis, MO, USA) is
reduced to purple formazan by dehydrogenase in the mitochondria of living cells. HIG-82
synoviocytes (3×10
4
) were plated in 12-well cultured plates for 24 h. The culture medium was
replaced with three types of media: (1) Control F12 culture medium containing folate supple-
mented with 10% undialyzed fetal bovine serum (FBS), designated as FC medium. (2) Marginal
folate deficient medium containing folate, but supplemented with dialyzed FBS (dFBS), desig-
nated as MFD medium. (3) Folated deficient medium containing no folate, thymidine, hypo-
xanthine, glycine and supplemented with 10% of dFBS, designated as FD medium. Other
experimental groups were MFD plus 1 μM folate and FD plus 1 μM folate. Synoviocytes culti-
vated with these types of media were allowed to grow for 1, 2 and 3 days. The viability of the
cells was then determined by MTT test. Cells were incubated with 500 μl of MTT solution (0.5
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 3/21
mg/ml) for 2 hr at 37°C, and the solution was replaced with 500 μl DMSO after the incubation.
The absorbance of DMSO lysed solution was measured at OD 575 nm [26]. The data were
acquired, analyzed and plotted by the Sigma Plot 10.0 software.
Measurement of intracellular ROS by flow cytometry
Production of intracellular ROS was detected by flow cytometry using DCFH-DA probe
(Sigma-Aldrich, St. Louis, MO, USA). HIG-82 synoviocytes (1.5×10
5
) were plated in 6-cm cul-
ture dishes for 24 h. The culture medium was repla ced with three types of media: (1) FC
medium, (2) MFD medium and (3) FD medium for 48 h. Cells were treated with 10 μM
DCFH-DA for 30 min in the dark, washed once with PBS, collected by centrifugation, and then
suspended in PBS. Intracellular ROS levels indicated by the fluorescence of dichlorofluorescein
(DCF) were evaluated by excitation at 488 nm and measured through a 530/22-nm barrier fil-
ter using a Becton-Dickinson FACSan flow cytometer [25]. The data were acquired, analyzed
and plotted by the CellQuest Pro software and the Sigma Plot 10.0 software.
Measurement of intracellular calcium levels by flow cytometry
Intracellular calcium levels were detected by flow cytometry using Fluo3-AM probe (Invitro-
gen, CA, USA). HIG-82 synoviocytes (1.5×10
5
) were plated in 6-cm culture dishes for 24 h.
The culture medium was replaced with three types of media: (1) FC medium, (2) MFD medium
and (3) FD medium for 48 h. After treatment, cells were trypsinized by trypsin, treated with
2 μM Fluo3-AM for 30 min in the dark, washed twice with PBS, collected by centrifugation,
and then suspended in PBS. Intracellular calcium levels were evaluated by excitation at 488 nm
and measured through a 530/22-nm barrier filter using a Becton-Dickinson FACSan flow
cytometer [27]. The data were acquired, analyzed and plotted by the CellQuest Pro software
and the Sigma Plot 10.0 software.
Measurement of intracellular GSH depletion
HIG-82 synoviocytes (1.5×10
5
) were plated in 6-cm culture dishes for 24 h. The culture
medium was replaced with three types of media: (1) FC medium, (2) MFD medium and (3) FD
medium for 48 h. After treatment, cells were incubated with 5 μM CMF-DA for 20 min at 37°C
in a 5% CO
2
incubator, washed once with PBS, collected by centrifugation, suspended in PBS,
and then measured through a 530/22-nm barrier filter using a Becton-Dickinson FACSan flow
cytometer. The CMF fluorescence gives a measure of the intracellular GSH level. The low CMF
fluorescence represents the cellular percentages of GSH depletion [26]. The data were acquired,
analyzed and plotted by the CellQuest Pro software and the Sigma Plot 10.0 software.
Apoptosis and cell cycle analysis
Apoptosis and cell cycle were measured with propidium iodide (PI) staining and flow cytome-
try. HIG-82 synoviocytes (1.5×10
5
) were plated in 6-cm culture dishes for 24 h. The culture
medium was replaced with three types of media: (1) FC medium, (2) MFD medium and (3) FD
medium for 48 h. After treatment, cells were collected, washed with PBS, fixed in PBS-metha-
nol (1:2, volume/volume) solution, and then maintained at 4°C for at least 18 h. After once
wash with PBS, the cell pellets were stained with a PI solution containing PBS, PI (40 μg/mL)
and DNase-free RNase A (40 μg/mL) for 30 min at room temperature in the dark. The cell pel-
lets were then analyzed using a Becton-Dickinson FACSan flow cytometer (Franklin Lakes,
NJ). PI is an ***intercalating agent and a fluorescent molecule that stains double-stranded
DNA. In metha nol-fixed cells, the PI molecules translocate into the nucleus and bind to the
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 4/21
double-stranded DNA. The PI fluorescent intensity in apoptosis cells was weaker than that of
cells in the G1 phase. The percentage of apoptosis cells was characterized as the percentage of
cells in the SubG1 region of the DNA distribution histograms. A minimum of 1 × 10
4
cells was
counted per sample [25]. The data were acquired, analyzed and plotted by the CellQuest Pro
software and the Sigma Plot 10.0 software.
Measurement of mitochondrial membrane permeability
The mitochondrial membrane permeability transition event in whole cell samples was used the
JC-1 potentiometric dye. HIG-82 synoviocytes (1.5×10
5
) were plated in 6-cm culture dishes for
24 h. The culture medium was replaced with three types of media: (1) FC medium, (2) MFD
medium and (3) FD medium for 48 h. After treatment, the cells were trypsinized, and then
incubated with 15μM JC-1 for 10 min at 37°C in a CO
2
incubator. This cyanine dye accumu-
lates in the mitochondrial matrix under the influence of the mitochondrial membrane poten-
tials and forms JC-1 aggregates, which have characteristic absorption and emission spectra.
Once membrane potentials decrease, JC-1 aggregates depart from mitoch ondrial matrix and
change to JC-1 monomers, in the meantime, JC-1 changes color from orange to green. Revers-
ible formation of JC-1 aggregates causes a shift of emitted light from 530 nm to 590 nm. Fol-
lowing the incubation step, the changed fluorescence level of JC-1 was analyzed using a
Becton-Dickinson FACScan flow cytometer [28]. The data were acquired, analyzed and plotted
by the CellQuest Pro software and the Sigma Plot 10.0 software.
TUNEL assay
HIG-82 synoviocytes (1.5×10
5
) were plated in 6-cm culture dishes for 24 h. The culture
medium was replaced with three types of media: (1) FC medium, (2) MFD medium and (3) FD
medium for 48 h. Cells were fixed in 1% paraformaldehyde in PBS for 30 min, then washed
with PBS, and stored in 70% methanol at 4°C. After rehydration in PBS, cells were assayed with
Apoptosis Detection Kit (APO-BRDU) (BD Pharmigen) [29]. The data were acquired, ana-
lyzed and plotted by the CellQuest Pro software and the Sigma Plot 10.0 software.
Western blotting analysis
HIG-82 synoviocytes (1.5×10
5
) were plated in 6-cm culture dishes for 24 h. The culture
medium was replaced with three types of media: (1) FC medium, (2) MFD medium and (3) FD
medium for 48 h. After treatment, cells were washed with PBS, resuspended in a protein extrac-
tion buffer for 10 min, and centrifuged at 12,000g for 10 min at 4°C to obtain total extracted
proteins (supernatant). Protein concentrations were measured with a Bio-Rad protein assay
reagent (Bio-Rad, Richmond, CA). The extracted cellular proteins were boiled in loading
buffer, and an aliquot corresponding to 60 μg of protein was separated on a 12% SDS-poly-
acrylamide gel. After electrophoresis, proteins were electrotransferred onto a polyvinylidene
fluoride transfer membrane. After blotting, the membranes were incubated with various pri-
mary antibodies overnight and then washed with PBST solution (0.05% Tween 20 in PBS). Fol-
lowing washing, the secondary antibody labeled with horseradish-peroxidase was added to the
membrane for 1 h and then washed with PBST solution (0.05% Tween 20 in PBS). The anti-
gen-antibody complexes were detected by enhanced chemiluminescence (Amersham Pharma-
cia Biotech, Piscataway, NJ) with a chemiluminescence analyzer [25].
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 5/21
HPLC quantitative analysis of folic acid in cells and media
HIG-82 synoviocytes (3×10
5
) were plated in 100-mm cultured dishes for 24 h. The culture
medium was replaced with FC medium, MFD medium or FD medium. Synoviocytes cultivated
with these three types of media were allowed to grow for 48 h. After treatment, the cells were
collected, twice washed with PBS, added 1 mL MeOH/PBS (7/3, v/v) using ultrasonic cell dis-
ruption for 30 min, then was filtered through a 0.47 μm filter. The cells lysed samples were
used to measured folate concentrations using HPLC followed by UV (280nm) detection. The
concentrations of folate in media and cells were evaluated by HPLC, respectively. For HPLC
analysis using with RP-C
18
column (4.6 mm × 250 mm, 5 μm, Merck, Germany), a mobile
phase consisting of 40 mM sodium phosphate dibasic heptahydrate buffer, and 5% acetonitrile
(v/v), pH 5.5. The mobile phase was filtered through a 0.47 μm filter and then deaerated ultra-
sonically prior to use. Folate was quantified by a UV detector at the wavelength of 280 nm fol-
lowing HPLC separation. Flow rate was 1.0 mL/min, the injection volume was 10 μL and the
column temperature was maintained at 25°C. The chromatographic peak of the analyte was
confirmed by comparing its retention time (tR 15.8 ± 0.2 min) with the reference standard.
Quantification was carried out by the integration on area under curve (AUC) of the peak using
external standard method. The working calibration curve based on folic acid standard solutions
showed good linearity over the range of 0.07810 μg/mL. The regression line for folate was
y = 34599x 1019.6 (R2 = 0.9999), where y is the peak area of folate, and x is the concentration
(μM) [30]. The data were acquired, analyzed and plotted by the Sigma Plot 10.0 software.
Measurement of caspase 8 and caspase 9 activities by flow cytometry
The caspase substrates, FITC-IETD-FMK for caspase 8 and FITC-LEHD-FMK for caspase 9,
were diluted with a buffer to make the desired concentrations of various homogeneous sub-
strate reagents. After treatment, the cells were washed once with PBS, detached by trypsiniza-
tion, and collected by centrifugation. Aliquot 1×10
5
cells were suspended in an F-12 medium,
and then various homogeneous substrate reagents were added to the cells, maintaining a 1:1
ratio of reagent to cell solution. After 1 h of incubation at 37° C, the cells were washed once
with PBS, collected by centrifugation, and suspended in PBS. FITC-IETD-FMK and FIT-
C-LEHD-FMK are cell permeable, nontoxic, and irreversibly which can bind to activated cas-
pase 8 and caspase 9 in apoptotic cells, respectively. The FITC label allows detection of
activated caspase 8 and caspase 9 in apoptotic cells directly by flow cytometry with excitation
wavelength set at 488 nm and emission wavelength at 520 nm [25]. The data were acquired,
analyzed and plotted by the CellQuest Pro software and Sigma Plot 10.0 software.
Statistic analysis
Data are presented as the mean (SD) of at least 3 independent experiments and were analyzed
using Students t-test by the Sigma Plot 10.0 software. A P value < 0.05 was considered statisti-
cally significant.
Results
FD impedes the growth of synoviocytes
When synoviocytes were cultivated in FC and MFD medium, a progressive time-dependent
increment of cell growth for up to 72-h could be observed. In contrast, HIG-82 synoviocytes
cultivated under FD condition, the growth rate of synoviocytes were found to be severely
retarded (Fig 1A). The cell viability is partially recovered in MFD and FD by 1 μM of folate
supplement in media. An experimental measure of folate (in cells and media) was
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 6/21
Fig 1. Folate deficiency impedes the growth of synoviocytes. (A) HIG-82 synoviocytes (3×10
4
) or (B) HIG-82 synoviocytes (3×10
5
) were plated in 12-well
culture plates or 100-mm cultured dishes, respectively, for 24 h. The culture medium was replaced with three types of media: (1) Control F12 culture medium
containing folate supplemented with 10% undialyzed fetal bovine serum (FBS), designated as FC medium. (2) Marginal folate deficient medium containing
folate, but supplemented with dialyzed FBS (dFBS), designated as MFD medium. (3) Folated deficient medium containing no folate, thymidine,
hypoxanthine, glycine and supplemented with 10% of dFBS, designated as FD medium. Other experimental groups were MFD plus 1 μM folate (FA) and FD
plus 1 μM folate. (A) Synoviocytes cultivated with these types of media were allowed to grow for 1, 2 and 3 days. The viability of the cells was then determined
by MTT assay. (B) Synoviocytes cultivated with FC, MFD, and FD media and allowed to grow for 48 h. The concentrations of folate in media and cells were
evaluated by HPLC. Illustrate chromatograms of the folate studied the analyzed cell lysed samples (FC, FD, and MFD medium). The retention time for folate
was tR 15.8 ± 0.2 min. LC C-18 column 5 μm (250 mm × 4.6 mm) and a mobile phase, consisting of 40 mM sodium phosphate dibasic, heptahydrate buffer,
and 5% acetonitrile (v/v), pH 5.5. The values shown are expressed as mean ± SD (n = 58 samples per experiment). Significant differences from the FC
group are p<0.05 (*), p<0.01 (**), p<0.001 (***).
doi:10.1371/journal.pone.0146440.g001
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 7/21
incorporated. To suggest experimental thoroughness, support the accurate definition of the
various culture conditions (FC, MFD vs FD) used in the study and ensure that the experimental
regimen is indeed successful to achieve endogenous folate depletion. An experimental measure
of folate (in cells and media) was incorporated. As shown in Fig 1B, the folate concentration in
FD was decreased significantly in HIG-82 synoviocytes and media as compared with FC and
MFD (S1 Table). These results ensure that the experimental regimen is indeed successful to
achieve endogenous folate depletion.
FD triggers apoptosis of synoviocytes
Two different types of experiments were conducted in order to ascertain that FD-induced cell
demise was apoptotic in nature. First, we performed cell cycle analysis and found that the per-
centage of sub G1 fraction (apoptosis) of HIG-82 synoviocytes grown in FD medium for 2-day
rose significantly to 19.04±4.3%. Comparatively, the sub G1 fractions of synoviocytes culti-
vated under either MFD or FC condition were relatively minimal (0.13±0.09% and 0.10
±0.05%, respectively) (Fig 2A and S1 Fig). Second, we also performed TUNEL assay and found
that TUNEL-positive fraction of HIG-82 synoviocytes cultivated under FD condition was sig-
nificantly higher than those either grown under MFD or FC controls (15.43±0.53% vs 4.17
±0.58% and 3.90±0.77%, respectively) (Fig 2B and S2 Fig).
FD provokes increased ROS production and triggers elevated calcium
release
ROS production of synoviocytes cultivated under FC, MFD or FD condition was evaluated
flowcytometrically using DCFH-DA as the probe. As compared to the FC control, ROS gener-
ated by FD group was nearly two-fold higher than FC control as reflected by the DCF fluores-
cent intensity being measured (Fig 3A). In parallel, intracellular calcium levels were also
evaluated flowcytometrically using fluo3-AM as the probe. Again, as compared to the FC con-
trol, there was a nearly 3-fold increase of intracellular calcium levels being detected in FD
group (Fig 3B). The histograms are rather broad indicating that the cellular calcium might be
measured in two different populations of cells. These data implicate that FD-induced ROS pro-
duction serves as a mediator for intracellular calcium release.
Evidence that FD-evoked ROS production is originated from
mitochondrial complex II and NADPH oxidase
To identify the possible originating sites of elevated ROS generation instigated by FD condi-
tion, we employed various ROS inhibitors. As indicated in Fig 4A, we demonstrated that FD-
evoked ROS production could not be suppressed by inhibitors of mitochondrial complex I
(rotenone) and mitochondrial complex III (antimycin A). Conversely, we found that inhibitors
specific for mitochondrial complex II (TTFA and carboxin) and NADPH oxidase (AEBSF and
apocynin) could effectively suppress FD-instigated ROS overproduction. Interestingly,
BAPTA, a Ca
2+
chelator, was found to be incapable of inhibiting FD-instigated ROS produc-
tion indicating that intracellular Ca
2+
release may be a downstream event of ROS gen eration.
In addition, we provided comparative data for inhibitor treatments in FC and MFD growth
conditions. In Fig 4B and 4C, the cell viabilities in all inhibitor treatments in FC and MFD were
maintained above 85%. Taken together, our data clearly indicate that FD-evoked ROS overpro-
duction is originated from NADPH oxidase and mitochondrial complex II.
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 8/21
Fig 2. Folate deficiency provokes apoptotic lethality in synoviocytes. HIG-82 synoviocytes (1.5×10
5
) were plated in 60-mm cultured dishes for 24 h. The
culture medium was replaced with FC, MFD, and FD media and then continued cultivating for additional 48 h. (A) Cells were then collected, washed with
PBS, fixed in PBS-methanol (1:2 v/v) solution and maintained at 4°C for at least 18 h. After one washed with PBS, the cell pellets were then stained with a PI
solution containing PBS, PI (40μg/mL), and DNase-free RNase A (40μg/mL) for 30 min at RT in the dark. The cell pellets were then analyzed using a Becton-
Dickinson FACSan flowcytometer. The epirubicin (500 nM) treatment (Epi) is a positive control assay of apoptosis. The blank bar, gray bar, right slash bar
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 9/21
Inhibition of FD-evoked ROS production concomitantly suppresses
intracellular calcium release and attenuates apoptosis of synoviocytes
In this study, we first demonstrated that FD-evoked ROS production in synoviocytes could not
be suppressed by inhibitors specific for mitochondrial complex I (rotenone) and complex III
(antimycin A). Concomitantly, both inhibitors were found to be incapable of curtailing the
release of intracellular calcium levels and attenuating the magnitude of apoptosis. In contrast,
we uncovered that FD-evoked overproduction of ROS could be strongly suppressed by inhibi-
tors of NADPH oxidase (AEBSF and apocynin) and Complex II (TTFA and carboxin). This
and left slash bar represent FC, MFD, FD and Epi treatment, respectively. The percentages of subG1 population determined by the PI fluorescent intensity in
apoptosis cells which was weaker than that of cells in the G1 phase. The percentages of apoptosis cells were characterized as the percentages of cells in the
SubG1 region of the DNA distribution histograms. The FD subG1 bar graph is compared with FC or MFD. A p<0.05 (*) was considered statistically
significant. (B) Cells were fixed in 1% paraformaldehyde in PBS for 30 min, then washed with PBS, and stored in 70% methanol at 4°C. After rehydration in
PBS, cells were evaluated with TUNEL assay. The values shown are mean ± SD (n = 58 samples per experiment). Significant differences from the FC or
MFD groups are p<0.05 (*), p<0.01 (**), p<0.001 (***).
doi:10.1371/journal.pone.0146440.g002
Fig 3. Folate deficiency triggers increased production of ROS and plethorically release of intracellular calcium levels. HIG-82 synoviocytes
(1.5×10
5
) were plated in 60-mm cultured dishes for 24 h. The cultured media were replaced with FC, MFD, and FD media and then continued cultivating for
additional 48 h. H
2
O
2
(400μM) treatment for 30 min and thapsigargin (TG; 10μM) treatment for 10 min were the positive control groups of ROS and
intracellular calcium, respectively. (A) Intercellular ROS was detected flowcytometrically using DCFH-DA staining. The red line, green line, blue line and
purple line represent FC, MFD, FD and H
2
O
2
treatments, respectively. (B) Intracellular calcium concentration was also measured flowcytometrically using
Fluo-3 AM staining. The red line, green line, blue line and purple line represent FC, MFD, FD and TG treatments, respectively. The peaks in each panel
represent the mean fluorescence intensities. The values shown are mean ± SD (n = 58 samples per experiment). Significant differences from the FC or
MFD groups are p<0.05 (*), p<0.01 (**), p<0.001 (***).
doi:10.1371/journal.pone.0146440.g003
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 10 / 21
phenomenon was accompanied with the drastic reduction of intracellular calcium release (Fig
5A). Consequently, FD-induced apoptotic lethality could be effectively attenuated (Fig 5B).
Our data clearly confirm that FD-evoked ROS production can serve as a mediator for the pro-
duction of intracellular calcium release that eventually fostering the occurrence of apoptosis of
synoviocytes. Finally, the alternate biochemical experiments to test for apoptosis under all the
growth conditions and markers for oxidative stress were evaluated. In Fig 6A and 6E, the cas-
pase 3 (an executioner caspase) and caspase 8 (an initiator caspase) were activated in MFD and
FD treatments as compared with FC treatment (S3 Fig). The caspase 9, an initiator caspase,
was activated in FD treatment but not in MFD treatment (Fig 6F and S4 Fig). The mitochon-
drial transmember potential disruption was significantly increased to 27% of cells in FD treat-
ment as compared with the FC and MFD treatments which were less than 7% (Fig 6B).
Glutathione depletion and expressions of gp91 and p22 (two NADPH oxidase subunits) are
two markers of oxidative stress [31,32]. In FC and MFD treatments, the GSH depletion was
Fig 4. Identification of originating sites of FD-evoked ROS overproduction using a group of specific inhibitors. HIG-82 synoviocytes (1.5×10
5
) were
plated in 60-mm cultured dishes for 24 h. (A) HIG-82 synoviocytes were separately grown under FC, MFD and FD media. Except for FC and MFD groups,
cells in FD group were pretreated with or without various concentrations of designated inhibitors including rotenone (R, mitochondrial complex I; 20 nM),
2-thenoyltrifluoroacetone (TTFA, mitochondrial complex II; 5 μM), carboxin (Car, mitochondrial complex II; 5μM), antimycin A (AA, mitochondrial complex III;
0.01 nM), 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (AEB, NADPH oxidase; 1μM), apocynin (Apo, NADPH oxidase; 30μM), and N-
acetylcysteine (NAC, antioxidant; 20 mM) for 2 h. BAPTA (BAP, Ca
2+
chelator; 5μM) was used as the control and pretreatment duration was 3 h. Intracellular
ROS production was then detected flowcytometrically using DCFH-DA staining. (B) and (C) The inhibitor treatments in FC and MFD growth conditions were
evaluated by MTT assay. The values shown are mean ± SD (n = 58 samples per experiment). Significant differences from the FC group are p<0.05 (*) and
the untreated FD group are p<0.01 (##), p<0.001 (###), respectively. The NS represents no significant difference from the untreated FD group.
doi:10.1371/journal.pone.0146440.g004
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 11 / 21
Fig 5. Effects of site-specific inhibitors on intracellular Ca
2+
release and their resultant consequences
on the extents of apoptotic lethality in FD-cultivated synoviocytes. (A) HIG-82 synoviocytes were
handled as those described in Fig 4. (A) The Ca
2+
concentration being released was measured
flowcytometrically using Fluo-3 AM staining. (B) The corresponding apoptosis indices in (A) were determined
using TUNEL assay. Significant differences from the untreated FD group are p<0.05 (*) and p<0.001 (***).
The NS represents no significant difference from the untreated FD group.
doi:10.1371/journal.pone.0146440.g005
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 12 / 21
Fig 6. The alternate biochemical experiments to test for apoptosis under all the growth conditions and markers for oxidative stress. (A) Caspase 3
activation after treatment with FC, MFD, FD and epirubicin (Epi). HIG-82 synoviocytes (3×10
5
/100-mm cultured dishes) were treated with FC, MFD and FD
for 48 h or 500 nM Epi (a positive control) for 48 h. The cleaved caspase 3 represented the caspase 3 activation was determined by western blotting. (B)
Mitochondrial transmembrane potential disruption after treatment with FC, MFD, FD and CCCP. HIG-82 synoviocytes (1.5×10
5
/60-mm cultured dishes) were
treated with FC, MFD and FD for 48 h or 200μM CCCP (a positive control) for 24 h. After treatment, the culture medium was replaced with a new medium with
15 μM JC-1 for 20 min in the dark. Bivariate plots of red versus green fluorescence shows an evaluation of mitochondrial transmembrane potential. Values in
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 13 / 21
less than 10% of cells (Fig 6C). FD treatment resulted in 28% of GSH depletion (Fig 6C). In Fig
6D, the expressions of gp91 and p22 was increased to about 3.2-fold and 5.0-fold in FD treat-
ment, respectively, as compared with FC treatment.
Effect of FD on the growth of HeLa cells
To evaluate the effect of FD on regular laboratory HeLa cell line, the HeLa cells were cultivated
in FC, MFD and FD media. As shown in Fig 7, the cell viability increases in a time-dependent
manner in all experimenta l groups. It is indicating that FD does not impede the cell growth in
HeLa cancer cells. Cancer cells may use some survival mechanisms to against FD.
Discussion
Folate deprivation (FD) is prevalent in many kinds of disorders. Osteoarthritis (OA), mainly
resulting from the regression of cartilage, chronic inflammation of the synovium and the sub-
chondral bone remodeling. Recently, other studies demonstrate that cadherin-11 involves in
synovitis and increases th e migratory and invasive capacity of fibroblast-like synoviocytes of
osteoarthritis [33]. Other reports also indicate that interleukin-1β up-regulates the expressions
of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in osteoarthritis
fibroblast-like synoviocytes via nuclear factor -κB-mediated mechanism [34]. Enhancement of
leukocytes infiltration and up-regulation of proinflammatory mediators play a crucial role in
OA pathophysiology [34]. The effects of FD on synoviocytes in vitro remain unclear. There-
fore, our study aimed to investigate whether FD resulted in effects on the HIG-82 synoviocytes.
The synoviocytes, a synovial intimal cell, are believed to be responsible for the production of
synovial fluid components, for absorption from the joint cavity, and for blood/synovial fluid
exchanges. Two types of synoviocytes, macrophagic cells (type A cells) and fibroblast-lik e cells
(type B cells) have been identified. The type B cells, which are suitable synoviocytes, are
involved in production of specialized matrix elements including hyaluronan, collagens and
fibronectin for the intimal interstitium and synovial fluid. In some mammals, type B cells show
characteristics suggesting sensory and endocrine functions, but these are not recognized in
other species. The synoviocytes, which form a discontinuous cell layer, grow both fragmented
basement membranes around the cells and junctional apparatus such as desmosomes and gap
junctions [35]. HIG-82, a type B synoviocytes, is a continuous cell line isolated from soft tissue
lining the knee joints of rabbits. This cell line was produced by spontaneous establishment of
an aging, late-passage culture of primary cells. HIG-82 cells can be used as many experimental
pathophysiologic models and activated by a number of stimuli, including phorbol myristate
acetate, interleukin-1, and the endocytosis of latex beads. Activated HIG-82 cells secrete colla-
genase, gelatinase, caseinase, and prostaglandin E2 into their culture medium. The HIG-82 cell
each box express cellular percentages of decreased mitochondrial transmembrane potential. The values shown are mean ± standard deviation (n = 58).
Significant differences from the FC group are p<0.05 (*), p<0.01 (**), p<0.001 (***) and the MFD group are p<0.01 (##). (C) Glutathione depletion after
treatment with FC, MFD, FD and buthionine sulphoximine (BSO). HIG-82 synoviocytes (1.5×10
5
/60-mm cultured dishes) were treated with FC, MFD, FD or
0.5 mM BSO (a positive control) for 48 h. The cellular percentages of glutathione depletion were evaluated by CMF-DA staining and flow cytometry. Data
show the percentages of cells displaying intracellular GSH depletion. The values shown are mean ± standard deviation (n = 58). Significant differences from
the FC group are p<0.05 (*), p<0.01 (**), p<0.001 (***) and the MFD group are p<0.05 (#). (D) Expressions of gp91 and p22 after treatment with FC, MFD,
FD. HIG-82 synoviocytes (3×10
5
/100-mm cultured dishes) were treated with FC, MFD and FD for 48 h. The expressions of gp91 and p22 were determined by
western blotting. (E) Caspase 8 activation after treatment with FC, MFD, FD and TNF-α. HIG-82 synoviocytes (1.5×10
5
/60-mm cultured dishes) were treated
with FC, MFD and FD for 48 h or 100 ng/ml TNF-α (a positive control) for 24 h. The caspase 8 activation was determined as outlined in Materials and
Methods. The values shown are mean ± standard deviation (n = 58). Significant differences are P<0.001 (***). (F) Caspase 9 activation after treatment with
FC, MFD, FD and epirubicin (Epi). HIG-82 synoviocytes (1.5×10
5
/60-mm cultured dishes) were treated with FC, MFD and FD for 48 h or 500 nM Epi (a
positive control) for 24 h. The caspase 9 activation was determined as outlined in Materials and Methods. The values shown are mean ± standard deviation
(n = 58). Significant differences are P<0.001 (***).
doi:10.1371/journal.pone.0146440.g006
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 14 / 21
line should facilitate research into the biology and biochemistry of the fibroblastic cells. Such
cells are likely to be important in the pathophysiology of some arthritis, including OA [36].
The folate metabolic pathway is important in several biological processes, including purine
and pyrimidine synthesis and the methylation of DNA and proteins [37]. Reduced folate (tetra-
hydrofolate) is the proximal single carbon donor in several reactions involved in the de novo
synthetic pathways for purine and pyrimidine precursors of DNA and RNA required for cell
proliferation [38]. Furthermore, tetrahydrofolate plays a part in a second important biochemi-
cal step: the methionine homocysteine cycle, which is necessary to provide a methyl group for
several downstream reactions such as methylation of DNA, RNA proteins, and others [38].
Once folate depletion in synoviocytes many cell functions will not normal process and results
in cell death or inhibition of cell proliferation. Fig 1A shows an almost doubling of viability
even in the FD grown cells. We speculate that there are little folate for cells to use from day 0 to
day 1 which results in doubling of via bility at day 1. However, the folate might complete defi-
ciency resulted in the viability did not increase from day 1 to day 3. There are a large popula-
tion is in G1 in the FD grown cells indicating that many cells were survival but stopped
division.
Fig 7. Folate deficiency does not impede the cell growth in HeLa cells. HeLa cells (3×10
4
) were plated in 12-well culture plates for 24 h. The culture
medium was replaced with three types of media: (1) Control DMEM/F-12 1:1 medium containing folate supplemented with 10% undialyzed fetal bovine
serum (FBS), designated as FC medium. (2) Marginal folate deficient medium containing folate, but supplemented with dialyzed FBS (dFBS), designatedas
MFD medium. (3) Folated deficient medium containing no folate, thymidine, hypoxanthine, glycine and supplemented with 10% of dFBS, designated as FD
medium. Other experimental groups were MFD plus 1 μM folate (FA) and FD plus 1 μM folate. (A) Synoviocytes cultivated with these types of media were
allowed to grow for 1, 2 and 3 days. The viability of the cells was then determined by MTT assay. The values shown are expressed as mean ± SD (n = 58
samples per experiment).
doi:10.1371/journal.pone.0146440.g007
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 15 / 21
Despite a plethora of literature has documented that prolif ic accumulation of ROS-mediated
oxidative stress is believed to play a predominant role in the pathogenesis of OA as a result of
an apoptotic lethality and matrix degradation of chondrocytes of articular cartilage [1,2,3,39],
yet, information pertaining to possible involvement of synoviocyte functional abnormality in
OA has been scanty. Along this same vein, since matrix degradation engendered in OA has
been ascribable to the ROS-mediated activation of MMPs, one of the biochemical markers of
epithelial-to-mesenchymal transition (EMT) that governing the migratory ability of an metas-
tasis-prone cell types and was mediated by the activation of NF-κB transcription factor [40].
Coincidently, FD-instigated oxidative-nitrosative stress (ONS) observed in HepG2 cells is also
associated with ROS triggered activation of NF-κB[24]. Based on the above-noted rationale,
we thus hypothesize that FD episode could capacitate both chondrocytes and synoviocytes to
activate MMPs through oxidative stress engendered by FD-triggered NF-κB activation. For
this reason, we conducted the study here aiming to delineate whether synoviocytes cultivated
under FD condition could poise themselves to apoptotic cell death. Furthermore, we also
wanted to identify the originating site of ROS overproduction in MRC based on the previous
report indicating that OA was associated with the mitochondrial dysfunction [1].
In our current study, we first demonstrated that synoviocyte (HIG-82) cell type cultivated
under FD could induce cell growth impediment and triggered apoptotic lethality as evident by
increased sub G1 fraction as well as elevated percentage of TUNEL-positive apoptotic cells.
Further studies using site specific inhibitors of complexes in MRC, we were able to pinpoint
the sites of the origin of ROS overproduction, namely: mitochondrial complex II and NADPH
oxidase (NOX). Concomitantly, we also uncovered that ROS overproduction elicited cytosolic
Ca
2+
overload which was the downstream event of the former process . Both ROS overproduc-
tion and elevated Ca
2+
released had been demonstrated to be the dual culprits for apoptotic
lethality during an episode of FD condition. Interestingly, several literatures reported that
folate deprivation-instigated diseases such as neural tube defects and congenital heart disease
could be rescued by the supplementation strategy [13,41]. Under this premise, we speculate
that folate supplementation strategy may be a preventive measure to rescue both chondrocytes
and synoviocytes from FD-induced apoptosis and thus the risk of the occurrence of OA can be
reduced.
Recently, Ralph et al. [42] reported that succinate dehydrogenase (SDH)/complex II system
could act as a key redox regulator of ROS production via an electron driving mechanism. This
study prompts us to investigate whether FD-evoked ROS overproduction can be similarly orig-
inated from SDH/complex II. This hypothesis turns out to be true since we utilize the site spe-
cific inhibitors of mitochondrial complex II (TTFA and carboxin) could strongly inhibit the
ROS overproduction engendered by FD condition. In contrast, site specific inhibitors for com-
plex I and III caused minimal effect on ROS production under similar FD condition. Along
this same vein , we unexpectedly unveiled that ROS overproduction engendered by FD condi-
tion could also be strongly suppressed by NADPH oxidase (NOX) inhibitors (AEBSF and
Apocynin). Our results are in accordance with the finding that folate supplementation could
reduce homocysteine-induced superoxide anion (O
2
) production via NADPH oxidase
reported elsewhere [43,44]. Collectively, our data further strengthen the relevance of folate sup-
plementation strategy as a preventive measure for the occurrence of OA.
It is worthy of noting that pretreatment of BAPTA, a chelator for Ca
2+
, could not inhibit
ROS generation, but the pretreatment of synoviocytes with either complex II or NOX inhibi-
tors could inhibit the elevation of cytosolic Ca
2+
. These data implicate that ROS generation is
preceding to cytosolic Ca
2+
release during an episode of FD condition. In line with our studies,
Waypa et al [ 45] also demonstrated a significant increase in Ca
2+
release during hypoxia, a situ-
ation mimicry to synoviocytes microenvironment could trigger mitochondrial ROS generation
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 16 / 21
Fig 8. Diagrammatic scheme denoting the cascade of events that fostering folate deficient
synoviocytes to apoptosis.
doi:10.1371/journal.pone.0146440.g008
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 17 / 21
in pulmonary arterial myocytes. Ca
2+
is a ubiquitous intracellular ion which acts as a signaling
modulator in many cellular processes including cell proliferation, differentiation, survival and
cell death [46]. FD-instigated cytosolic Ca
2+
overload could thus be served as the arbitrator of
apoptosis probably through the activation of Ca
2+
dependent kinases and phosphatases [47].
In conclusion, our current studies uncovered that synoviocytes cultivated under FD condi-
tion could elicit ROS overproduction and elevation of cytosolic Ca
2+
release that triggered the
occurrence of apoptotic lethality. Along the same vein, we first identified the site of MRC that
initiated ROS overproduction being SDH/complex II, a major site for electron driving produc-
tion of ROS during an episode of FD condition suggesting that inhibitors for complex II may
be a targeting therapy to alleviate ROS production, Ca
2+
overload and the extents of apoptosis.
Lastly, we advocate the idea that folate supplementation strategy may be a suitable preventive
measure for the occurrence of OA due to proper preservation of chondrocytes and synovio-
cytes without undergoing apoptotic lethality. Finally, a diagrammatic scheme depicting the cas-
cade of events leading to FD-triggered apoptosis of synoviocytes can be seen in Fig 8.
Supporting Information
S1 Fig. Apoptosis effects (sub G1) and cell cycle on FC, MFD and FD treatment. HIG-82
synoviocytes (1.5×10
5
) were plate d in 60-mm cultured dishes for 24 h. The culture medium
was replaced with FC, MFD, and FD media and then continued cultivating for additional 48 h.
Cells were then collected, washed with PBS, fixed in PBS-methan ol (1:2 v/v) solution and
maintained at 4°C for at least 18 h. After one washed with PBS, the cell pellets were then
stained with a PI solution containing PBS, PI (40 μg/mL), and DNase-free RNase A (40 μg/mL)
for 30 min at RT in the dark. The cell pellets were then analyzed using a Becton-Dickinson
FACSan flowcytometer. Data in each panel represent the percentages of sub G1, G1, S and G2/
M phases.
(TIF)
S2 Fig. TUNEL analysis on FC, MFD and FD treatment. HIG-82 synoviocytes (1.5×10
5
)
were plated in 60-mm cultured dishes for 24 h. The culture medium was replaced with FC,
MFD, and FD media and then continued cultivating for additional 48 h. Cells were fixed in 1%
paraformaldehyde in PBS for 30 min, and then washed with PBS, and stored in 70% methanol
at 4°C. After rehydration in PBS, cells were evaluated with TUNEL assay. Data in each panel
represent the percentages of apoptosis. The values shown are mean ± SD (n = 58 samples per
experiment). Significant differences from the FC group are p<0.05 (
), p<0.001 (

) and the
MFD group are p<0.01 (##), respectively.
(TIF)
S3 Fig. Caspase 8 analysis on FC, MFD, FD and TNF-α treatments. HIG-82 synoviocytes
(1.5×10
5
) were plated in 60-mm cultured dishes for 24 h. The cultured media were replaced
with FC, MFD, and FD media for 48 h or 100 ng/ml TNF-α(a positive control) for 24 h. Ali-
quot 1×10
5
cells were suspended in an F-12 medium, and then homogeneous FIT-
C-IETD-FMK substrate reagent was added to the cells, maintaining a 1:1 ratio of reagent to cell
solution. After 1 h of incubation at 37°C, the cells were washed once with PBS, collected by cen-
trifugation, and suspended in PBS. The peaks represented the mean FITC fluorescence intensi-
ties in cells were analyzed using a Becton-Dickinson FACS-Calibur flow cytometer. The red
line, green line, blue line and purple line represent FC, MFD, FD and TNF-αtreatments,
respectively.
(TIF)
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 18 / 21
S4 Fig. Caspase 9 analysis on FC, MFD, FD and epirubicin (Epi) treatments. HIG-82 syno-
viocytes (1.5×10
5
) were plated in 60-mm cultured dishes for 24 h. The cultured media were
replaced with FC, MFD, and FD media for 48 h or 500 nM Epi (a positive control) for 24 h. Ali-
quot 1×10
5
cells were suspended in an F-12 medium, and then homogeneous FIT-
C-LEHD-FMK substrate reagent was added to the cells, maintaining a 1:1 ratio of reagent to
cell solution. After 1 h of incubation at 37°C, the cells were washed once with PBS, collected by
centrifugation, and suspended in PBS. The peaks represented the mean FITC fluorescence
intensities in cells were analyzed using a Becton-Dickinson FACS-Calibur flow cytometer. The
red line, green line, blue line and purple line represent FC, MFD, FD and epirubicin (Epi) treat-
ments, respectively.
(TIF)
S1 Table. Folate concentrations in cells and media.
(TIF)
Author Contributions
Conceived and designed the experiments: HCH FJL PJC TZL CHC. Performed the experi-
ments: HCH WMC JYW YWC CCH KHC CZH RHY. Analyzed the data: JYW CHC. Contrib-
uted reagents/materials/analysis tools: HCH WMC CHC. Wrote the paper: TZL CHC.
References
1. Blanco FJ, Lopez-Armada MJ, Maneiro E. Mitochondrial dysfunction in osteoarthritis. Mitochondrion.
2004; 4: 715728. PMID: 16120427
2. Li D, Xie G, Wang W. Reactive oxygen species: the 2-edged sword of osteoarthritis. Am J Med Sci.
2012; 344: 486490. PMID: 22885622
3. Buckwalter JA, Anderson DD, Brown TD, Tochigi Y, Martin JA. The Roles of Mechanical Stresses in
the Pathogenesis of Osteoarthritis: Implications for Treatment of Joint Injuries. 2013; Cartilage 4: 286
294. PMID: 25067995
4. Fox JT, Stover PJ. Folate-mediated one-carbon metabolism. Vitam Horm. 2008; 79: 144. doi: 10.
1016/S0083-6729(08)00401-9 PMID: 18804690
5. Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev. 2004; 62: S312; dis-
cussion S13. PMID: 15298442
6. Novakovic P, Stempak JM, Sohn KJ, Kim YI. Effects of folate deficiency on gene expression in the apo-
ptosis and cancer pathways in colon cancer cells. Carcinogenesis. 2006; 27: 916924. PMID:
16361273
7. Hsu HC, Chiou JF, Wang YH, Chen CH, Mau SY, Ho CT, et al. Folate deficiency triggers an oxidative-
nitrosative stress-mediated apoptotic cell death and impedes insulin biosynthesis in RINm5F pancre-
atic islet beta-cells: relevant to the pathogenesis of diabetes. PLoS One. 2013; 8: e77931. doi: 10.
1371/journal.pone.0077931 PMID: 24223745
8. Kao TT, Chu CY, Lee GH, Hsiao TH, Cheng NW, Chang NS, et al. Folate deficiency-induced oxidative
stress contributes to neuropathy in young and aged zebrafishImplication in neural tube defects and
Alzheimer's diseases. Neurobiol Dis.2014; 71: 234244. PMID: 25131448
9. Tjiattas L, Ortiz DO, Dhivant S, Mitton K, Rogers E, Shea TB. Folate deficiency and homocysteine
induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation. Aging Cell.
2004; 3: 7176. PMID: 15038821
10. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, et al. Homocysteine elicits a DNA damage
response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 2000;
20: 69206926. PMID: 10995836
11. Övey İS, Naziroğlu M. Homocysteine and cytosolic GSH depletion induce apoptosis and oxidative tox-
icity through cytosolic calcium overload in the hippocampus of aged mice: Involvement of TRPM2 and
TRPV1 channels. Neuroscience. 2015; 284: 225233. doi: 10.1016/j.neuroscience.2014.09.078
PMID: 25305668
12. Harrison RJ. Vitamin B12 levels in erythrocytes in anaemia due to folate deficiency. Br J Haematol.
1971; 20: 623628. PMID: 5089952
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 19 / 21
13. Czeizel AE, Dudas I, Vereczkey A, Banhidy F. Folate deficiency and folic acid supplementation: the
prevention of neural-tube defects and congenital heart defects. Nutrients. 2013; 5: 47604775. doi: 10.
3390/nu5114760 PMID: 24284617
14. Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev.
2013; 2013: 316523. doi: 10.1155/2013/316523 PMID: 23983897
15. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in
health, disease, and drug therapy. J Lab Clin Med. 1989; 114: 473501. PMID: 2681479
16. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;
10: 6688. PMID: 15539274
17. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a
meta-analysis. JAMA. 2002; 288: 20152022. PMID: 12387654
18. Sen U, Basu P, Abe OA, Givvimani S, Tyagi N, Metreveli N, et al. Hydrogen sulfide ameliorates hyper-
homocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol. 2009; 297: F410419.
doi: 10.1152/ajprenal.00145.2009 PMID: 19474193
19. Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC. Homocysteine causes cerebrovascular
leakage in mice. Am J Physiol Heart Circ Physiol. 2006; 290: H12061213. PMID: 16258031
20. Lindenbaum J, Allen RH. Clinical spectrum and diagnosis of folate deficiency. In: Bailey LB, editor.
Folate in Health and Disease. New York. 1995; pp. 4373.
21. Clarke R, Grimley Evans J, Schneede J, Nexo E, Bates C, Fletcher A, et al. Vitamin B12 and folate defi-
ciency in later life. Age Ageing. 2004; 33: 3441. PMID: 14695861
22. Lopez HL. Nutritional interventions to prevent and treat osteoarthritis. Part II: focus on micronutrients
and supportive nutraceuticals. 2012; PM R 4: S155168. doi: 10.1016/j.pmrj.2012.02.023 PMID:
22632695
23. Vacek TP, Kalani A, Voor MJ, Tyagi SC, Tyagi N. The role of homocysteine in bone remodeling. Clin
Chem Lab Med. 2013; 51: 579590. doi: 10.1515/cclm-2012-0605 PMID: 23449525
24. Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ. Folate deficiency-induced oxidative stress and apo-
ptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced
activation of NF-kappaB in human Hep G2 cells. Biomed Pharmacother. 2001; 55: 434442. PMID:
11686576
25. Yang JT, Li ZL, Wu JY, Lu FJ, Chen CH. An oxidative stress mechanism of shikonin in human glioma
cells. PLoS One. 2014; 9: e94180. doi: 10.1371/journal.pone.0094180 PMID: 24714453
26. Chen CH, Lin WC, Kuo CN, Lu FJ. Role of redox signaling regulation in propyl gallate-induced apopto-
sis of human leukemia cells. Food Chem Toxicol. 2011; 49: 494501. doi: 10.1016/j.fct.2010.11.031
PMID: 21112369
27. Yeh CH, Yang ST, Chen CH. Calvatia lilacina protein extract induces apoptosis through endoplasmic
reticulum stress in human colon carcinoma cells. Process Biochem. 2011; 46: 1599
1606.
28. Ong PL, Weng BC, Lu FJ, Lin ML, Chang TT, Hung RP, et al. The anticancer effect of protein-extract
from Bidens alba in human colorectal carcinoma SW480 cells via the reactive oxidative species- and
glutathione depletion-dependent apoptosis. Food Chem Toxicol. 2008; 46: 15351547. doi: 10.1016/j.
fct.2007.12.015 PMID: 18226850
29. Hsieh TJ, Liu TZ, Lu FJ, Hsieh PY, Chen CH. Actinodaphnine induces apoptosis through increased
nitric oxide, reactive oxygen species and down-regulation of NF-kB signaling in human hepatoma Mah-
lavu cells. Food Chem Toxicol. 2006; 44: 344354. PMID: 16168547
30. Lebiedzińska A, Dabrowska M, Szefer P, Marszałł M. High-performance liquid chromatography method
for the determination of folic acid in fortified food products. Toxicol Mech Method. 2008; 18, 463467.
31. Shah D, Mahajan N, Sah S, Nath SK, Paudyal B. Oxidative stress and its biomarkers in systemic lupus
erythematosus. J Biomed Sci. 2014; 21:23. doi: 10.1186/1423-0127-21-23 PMID: 24636579
32. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative
stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 17521761. PMID:
15599400
33. Ding X, Zhang Y, Huang Y, Liu S, Lu H, Sun T. Cadherin-11 involves in synovitis and increases the
migratory and invasive capacity of fibroblast-like synoviocytes of osteoarthritis. Int Immunopharmacol.
2015; 26: 153161. doi: 10.1016/j.intimp.2015.03.024 PMID: 25824718
34. Yang CR, Shih KS, Liou JP, Wu YW, Hsieh IN, Lee HY, et al. Denbinobin upregulates miR-146a
expression and attenuates IL-1β-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoar-
thritis fibroblast-like synoviocytes. J Mol Med. 2014; 92: 11471158.
35. Iwanaga T, Shikichi M, Kitamura H, Yanase H, Nozawa-Inoue K. Morphology and functional roles of
synoviocytes in the joint. Arch Histol Cytol. 2000; 63: 1731. PMID: 10770586
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 20 / 21
36. Georgescu HI, Mendelow D, Evans CH. HIG-82: an established cell line from rabbit periarticular soft tis-
sue, which retains the "activatable" phenotype. In Vitro Cell Dev Biol. 1988; 24: 10151122. PMID:
2846503
37. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mecha-
nisms and the evidence for folate's role. Adv Nutr. 2012; 3: 2138. doi: 10.3945/an.111.000992 PMID:
22332098
38. Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH. Anti-inflammatory mechanisms of methotrexate in
rheumatoid arthritis. 2001; Ann Rheum Dis 60:729735. PMID: 11454634
39. Yu DH, Yi JK, Yuh HS, Park S, Kim HJ, Bae KB, et al. Over-expression of extracellular superoxide dis-
mutase in mouse synovial tissue attenuates the inflammatory arthritis. Exp Mol Med. 2012; 44: 529
535. PMID: 22718219
40. Min C, Eddy SF, Sherr DH, Sonenshein GE. NF-kappaB and epithelial to mesenchymal transition of
cancer. J Cell Biochem. 2008; 104: 733744. doi: 10.1002/jcb.21695 PMID: 18253935
41. Wen SW, Zhou J, Yang Q, Fraser W, Olatunbosun O, Walker M. Maternal exposure to folic acid antago-
nists and placenta-mediated adverse pregnancy outcomes. CMAJ. 2008; 179: 12631268. doi: 10.
1503/cmaj.080859 PMID: 19047607
42. Ralph SJ, Moreno-Sanchez R, Neuzil J, Rodriguez-Enriquez S. Inhibitors of succinate: quinone reduc-
tase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells
from ischemic damage but induce specific cancer cell death. Pharm Res. 2011; 28: 26952730. doi:
10.1007/s11095-011-0566-7 PMID: 21863476
43. Hwang SY, Siow YL, Au-Yeung KK, House J, O K. Folic acid supplementation inhibits NADPH oxi-
dase-mediated superoxide anion production in the kidney. Am J Physiol Renal Physiol. 2011; 300:
F189198. doi: 10.1152/ajprenal.00272.2010 PMID: 20980407
44. Rogers EJ, Chen S, Chan A. Folate deficiency and plasma homocysteine during increased oxidative
stress. N Engl J Med. 2007; 357: 421422. PMID: 17652662
45. Waypa GB, Marks JD, Mack MM, Boriboun C, Mungai PT, Schumacker PT. Mitochondrial reactive oxy-
gen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res. 2002;
91: 719726. PMID: 12386149
46. Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca
2+
transfer in the control of apoptosis. Oncogene. 2008; 27: 64076418. doi: 10.1038/onc.2008.308
PMID: 18955969
47. Harr MW, Distelhorst CW. Apoptosis and autophagy: decoding calcium signals that mediate life or
death. Cold Spring Harb Perspect Biol. 2010; 2: a005579. doi: 10.1101/cshperspect.a005579 PMID:
20826549
Folate Deficiency Triggers Apoptosis of Synoviocytes
PLOS ONE | DOI:10.1371/journal.pone.0146440 January 15, 2016 21 / 21
... Specifically, recent studies have demonstrated that synoviocytes cultivated under FD conditions exhibit elevated reactive oxygen species (ROS) production and increased cytosolic Ca 2+ release, leading to apoptotic lethality [20]. This mechanistic insight is consistent with our results, suggesting that folate deficiency contributes to OA pathogenesis not only through impaired immune response but also by directly exacerbating cellular stress and apoptosis in joint tissues. ...
... This convergence of evidence highlights folate's potential as a modifiable factor in OA management and prevention. The protective effect of folate against OA progression, as indicated in both studies, suggests that folate supplementation could be a beneficial intervention in OA in reducing the risk or severity of OA in critical joints, underlining its role in preserving the integrity of chondrocytes and synoviocytes [20,21]. On the other hand, the identification of succinate dehydrogenase (SDH)/complex II as a major site for ROS production under FD conditions offers a potential therapeutic target to mitigate these effects [20]. ...
... The protective effect of folate against OA progression, as indicated in both studies, suggests that folate supplementation could be a beneficial intervention in OA in reducing the risk or severity of OA in critical joints, underlining its role in preserving the integrity of chondrocytes and synoviocytes [20,21]. On the other hand, the identification of succinate dehydrogenase (SDH)/complex II as a major site for ROS production under FD conditions offers a potential therapeutic target to mitigate these effects [20]. Considering our results, checking folate levels in OA patients could be recommended as part of the evaluation process. ...
Article
Full-text available
Context Folate deficiency is often observed in patients with inflammatory diseases, raising questions about its role in knee osteoarthritis (OA) progression. Objectives This study aimed to assess the association of folate deficiency with the clinical and radiological severity of knee OA. Methods A prospective cross-sectional study was conducted from January 1, 2019 to January 1, 2020. Primary knee OA patients referred to orthopedic clinics in Zabol, Iran were included. Radiographic severity was gauged utilizing the Kellgren–Lawrence (KL) classification. For clinical severity, patients completed the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire. IBM SPSS v.27 facilitated the statistical analysis. Results Forty-nine knee OA patients, averaging 67.45±13.44 years in age, were analyzed. Spearman correlation analysis revealed a negative correlation between folate levels and both WOMAC and KL scores. The correlation was stronger between folate and KL score (Spearman correlation coefficient: −0.75) than between folate and WOMAC total score (Spearman correlation coefficient: −0.46). Additionally, a significantly higher KL score was observed in patients with folate deficiency (p=0.004). Conclusions Our study highlights a significant correlation between folate deficiency and increased severity of OA, which is evident in radiological and clinical assessments. These findings suggest that folate plays a key role in OA pathogenesis and could be a modifiable factor in its management.
... It has been highlighted that the interaction between highest and lowest levels of serum folate and vitamin B12 respectively, being a common finding in these subjects, was associated to an increased risk of gestational diabetes [3]. For instance, the evidence by Saravanan et al. is challenging and essential to definitely confirm and translate into this clinical framework the association between the risk of diabetes and the vitamins' status observed using in vitro/in vivo models [3][4][5][6]. Indeed, as coenzymes, folate and B12 are involved in various biological pathways (i.e., aforementioned for the folate, whereas B12 mainly promotes fatty acids/amino acids degradation) whose balance is warranted by the maintenance of adequate levels of both vitamins in order to assure the normal physiological functions [6]. ...
... Indeed, as coenzymes, folate and B12 are involved in various biological pathways (i.e., aforementioned for the folate, whereas B12 mainly promotes fatty acids/amino acids degradation) whose balance is warranted by the maintenance of adequate levels of both vitamins in order to assure the normal physiological functions [6]. Undoubtedly, folate and particularly for its depletion, is the most investigated vitamin in the framework of gestational risk and diabetes [4][5][6][7]. In vitro models of the pathophysiology of diabetes have shown that the folate deficiency is associated with the apoptosis of islet β cells [4]. ...
... Undoubtedly, folate and particularly for its depletion, is the most investigated vitamin in the framework of gestational risk and diabetes [4][5][6][7]. In vitro models of the pathophysiology of diabetes have shown that the folate deficiency is associated with the apoptosis of islet β cells [4]. Noteworthy, the excessive exposure to FA may promote DNA methylation patterns thus contributing to trigger the inflammatory response, well characterized, although differentiated, in diabetes type I and II [5]. ...
... superoxide, thus modulating the oxidative stress-mediated pathway that has been shown to play a pivotal role in chronic pain. [43][44][45] In addition, experimental data have shown AP to inhibit NF-κB activation and upregulate Nrf2 gene expression with consequent downstream effects. 46 As for PA, it exerts its effect via inhibiting NF-κB activation with modulation of the inflammatory responses, through inhibition of proinflammatory cytokines TNF-α, IL-1β, IL-6, metalloproteinases and of MCP-1 expression. ...
... Experimental data in rodents indicate that AP may inhibit the pathway involved in transmitting neuropathic pain, 54 and several reports indicating a beneficial effect of these two compounds evaluated individually in animal models of neuropathic pain have been published. 43,44 In a streptozotocin-induced diabetic neuropathy rat model, AP was found to dose-dependently increase the pain threshold of the animals, and appeared to do so by decelerating the oxidative-stress-mediated pathology in the sciatic nerve under study. 55 Similarly, in an identical model, AP was found to partially reverse allodynia, along with reversal of oxidative-stress markers in the spinal cord. ...
... As mentioned in the introduction section, Hcy is considered a pro-oxidant agent that compromises the oxidative balance by different mechanisms [46,49,50]. Among its proposed mechanisms is the increase of multicomponent NOX enzyme complexes, which are one of the major producers of endogenous ROS in different tissues [11][12][13]45]. In this context, NOX plays a central role in liver fibrogenesis. ...
... Moreover, the ratio of cleaved caspase-3/caspase-3 is also reduced, indicating that apoptosis is decreased when FA hepatic levels are balanced, and that this vitamin plays an important role during BD liver damage. FA is known for its anti-apoptotic properties in different types of cells [13,[68][69][70][71]. These authors attribute this action to different mechanisms: through decreasing NOX activity-ROS generation-mitochondrial complex II; decreasing OS-, preventing telomeric DNA oxidation and attrition; regulating the expression of apoptosis-related genes (decreased caspase-3 and upregulated BCL2/BAX ratio); modulating microRNA-34a, associated with Bcl-2 signaling; or decreasing caspase-9 activity. ...
Article
Full-text available
Chronic ethanol consumption and liver disease are intimately related to folic acid (FA) homeostasis. Despite the fact that FA decreases lipid oxidation, its mechanisms are not yet well elucidated. Lately, adolescents have been practising binge drinking (BD), consisting of the intake of a high amount of alcohol in a short time; this is a particularly pro-oxidant form of consumption. The aim of this study is to examine, for the first time, FA homeostasis in BD adolescent rats and its antioxidant properties in the liver. We used adolescent rats, including control rats and rats exposed to an intermittent intraperitoneal BD model, supplemented with or without FA. Renal FA reabsorption and renal FA deposits were increased in BD rats; hepatic deposits were decreased, and heart and serum levels remained unaffected. This depletion in the liver was accompanied by higher transaminase levels; an imbalance in the antioxidant endogenous enzymatic system; lipid and protein oxidation; a decrease in glutathione (GSH) levels; hyper-homocysteinemia (HHcy); an increase in NADPH oxidase (NOX) 1 and NOX4 enzymes; an increase in caspase 9 and 3; and a decrease in the anti-apoptotic metallopeptidase inhibitor 1. Furthermore, BD exposure increased the expression of uncoupled endothelial nitric oxide synthase (eNOS) by increasing reactive nitrogen species generation and the nitration of tyrosine proteins. When FA was administered, hepatic FA levels returned to normal levels; transaminase and lipid and protein oxidation also decreased. Its antioxidant activity was due, in part, to the modulation of superoxide dismutase activity, GSH synthesis and NOX1, NOX4 and caspase expression. FA reduced HHcy and increased the expression of coupled eNOS by increasing tetrahydrobiopterin expression, avoiding nitrosative stress. In conclusion, FA homeostasis and its antioxidant properties are affected in BD adolescent rats, making it clear that this vitamin plays an important role in the oxidative, nitrosative and apoptotic hepatic damage generated by acute ethanol exposure. For this, FA supplementation becomes a potential BD therapy for adolescents, preventing future acute alcohol-related harms.
... Previous studies have indicated that the folate receptor is overexpressed on activated macrophages, which are closely related to osteoarthritis (Tsuneyoshi et al., 2012). Some literature has also showed that folic acid deficiency (FD) can mediate synovial cell apoptosis by affecting the excessive production of reactive oxygen species (ROS) induced by mitochondrial complex II and NOX and the sharp release of intracellular calcium (Ca2 +) concentration (Hsu et al., 2016). Besides, Duan W et al. proved that a folate receptor-targeted nanocarrier system can effectively block the NF-κB signaling pathway and reduce the expression of proinflammatory cytokines, so as to significantly inhibit the progression of arthritis in a mouse model (Duan and Li, 2018). ...
Article
Full-text available
Background: Osteoarthritis (OA) is a degenerative disease which serious affects patients. Ligusticum chuanxiong (CX) has been shown to have a certain curative effect on osteoarthritis in traditional Chinese medicine therapy. This study is based on network pharmacology and molecular docking technology to explore the potential mechanism of CX. Methods: Components of CX to treat osteoarthritis were screened in the TCMSP database and targets were predicted by the PharmMapper database, the osteoarthritis targets were collected from the GeneCards database, and intersection genes were found to be the possible targets of CX anti-OA. The STRING database and Cytoscape software were utilized for protein-protein interaction analysis and further screening of core targets. The Metascape database was used for KEGG and GO enrichment analyses. Then, the top 10 pathways were selected to construct “drug-compound-target-pathway-disease” network analysis. Finally, molecular docking was used to analyze the binding affinity of seven compounds with core targets and TNF-α. Results: Seven compounds with 253 non-repetitive targets of CX were screened from the TCMSP database and 60 potential intersection targets of CX anti-OA were found. PPI network analysis showed that the core targets were ALB, AKT1, IGF1, CASP3, MAPK1, ANXA5, and MAPK14, while GO and KEGG pathway enrichment analyses showed that the relevant biological processes involved in the treatment of osteoarthritis by CX might include the MAPK cascade and reactive oxygen species metabolic process. The KEGG pathway analysis result was mainly associated with the MAPK signaling pathway and PI3K-AKT signaling pathway. We further docked seven ingredients with MAPK1 and MAPK14 enriched in the MAPK pathway, and TNF-α as the typical inflammatory cytokine. The results also showed good binding affinity, especially FA, which may be the most important component of CX anti-OA. Conclusion: Our research revealed the potential mechanism of CX in the treatment of OA, and our findings can also pave the way for subsequent basic experimental verification and a new research direction.
... Similarly, disrupted cellular redox homeostasis by the accumulation of unmetabolized homocysteine has also been reported in vitamin B 12 -deficient worms that showed significant reduction in the activity of cobalamin-dependent methionine synthase [49]. Moreover, the results reported above were similar phenomena to those observed in mammals during folate deficiency [50,51], which reportedly induces severe oxidative stress, leading to DNA damage [52,53] and increased blood pressure and insulin resistance [54] in mammals. ...
Article
Full-text available
Using Caenorhabditis elegans as a model animal, we evaluated the effects of chronical supplementation with high-dose folic acid on physiological events such as life cycle and egg-laying capacity and folate metabolism. Supplementation of high-dose folic acid significantly reduced egg-laying capacity. The treated worms contained a substantial amount of unmetabolized folic acid and exhibited a significant downregulation of the mRNAs of cobalamin-dependent methionine synthase reductase and 5,10-methylenetetrahydrofolate reductase. In vitro experiments showed that folic acid significantly inhibited the activity of cobalamin-dependent methionine synthase involved in the metabolism of both folate and methionine. In turn, these metabolic disorders induced the accumulation of unmetabolized homocysteine, leading to severe oxidative stress in worms. These results were similar to the phenomena observed in mammals during folate deficiency.
... Previous studies investigating synovial-caused OA pathologies have several limitations (59)(60)(61)(62)(63): i) Cells are cultured only under normal oxygen partial pressure, thus physiological or pathological oxygen fluctuations are not considered; and ii) the effect on hypoxic tolerance of chondrocytes by fluctuating oxygen have been studied, while mitochondrial damage and respiratory dysfunction in oxygen dependent FLS have not been investigated in depth. Therefore, due to physiological and pathological H/R processes in joint organs, previous studies may have a certain level of bias (15). ...
Article
Full-text available
Hypoxia/reoxygenation (H/R) may play an important role via senescence in the mechanism of osteoarthritis (OA) development. The synovial membrane is highly sensitive to H/R due to its oxygen consumption feature. Excessive mechanical loads and oxidative stress caused by H/R induce a senescence‑associated secretory phenotype (SASP), which is related to the development of OA. The aim of the present study was to investigate the differences of SASP manifestation in synovial tissue masses between tissues from healthy controls and patients with OA. The present study used tumor necrosis factor‑α (TNF‑α) to pre‑treat synovial tissue and fibroblast‑like synoviocytes (FLS) to observe the effect of inflammatory cytokines on the synovial membrane before H/R. It was determined that H/R increased interleukin (IL)‑1β and IL‑6 expression levels in TNF‑α‑induced cell culture supernatants, increased the proportion of SA‑β‑gal staining, and increased the expression levels of high mobility group box 1, caspase‑8, p16, p21, matrix metalloproteinase (MMP)‑3 and MMP‑13 in the synovium. Furthermore, H/R opened the mitochondrial permeability transition pore, caused the loss of mitochondrial membrane potential (ΔΨm) and increased the release of reactive oxygen species (ROS). Moreover, H/R caused the expansion of the mitochondrial matrix and rupture of the mitochondrial extracorporeal membrane, with a decrease in the number of cristae. In addition, H/R induced activation of the JNK signaling pathway in FLS to induce cell senescence. Thus, the present results indicated that H/R may cause inflammation and escalate synovial inflammation induced by TNF‑α, which may lead to the pathogenesis of OA by increasing changes in synovial SASP and activating the JNK signaling pathway. Therefore, further studies expanding on the understanding of the pathogenesis of H/R etiology in OA are required.
... The underlying inflammation in the DRM + I group may have caused mitochondrial dysfunction, which would have been less pronounced in the DRM-I group. Several studies have related malnutrition with a rise of ROS in different types of diseases [11,[26][27][28]. In this sense, Hsu et al. reported high levels of ROS and altered mitochondrial function in subjects with folate deficiency, which suggests that mitochondrial dysfunction is a result of malnutrition [29]. ...
Article
Full-text available
Background: The aim of this study was to evaluate markers of inflammation, oxidative stress and endothelial function in a disease-related malnutrition (DRM) outpatient population. Methods: For this cross-sectional study, a total of 83 subjects were included and clustered in 3 groups: 34 with normonutrition (NN), 21 with DRM without inflammation (DRM-I) and 28 with DRM and inflammation (DRM + I). Nutritional diagnosis was conducted for all subjects according to ASPEN. Biochemical parameters, proinflammatory cytokines, reactive oxygen species production, glutathione, mitochondrial membrane potential, oxygen consumption, adhesion molecules and leukocyte-endothelium interactions were evaluated. Results: DRM + I patients showed lower albumin, prealbumin, transferrin, and retinol-binding protein levels with respect to the NN group (p < 0.05), differences that were less noticeable in the DRM-I group. DRM + I was associated with a significant increase in hsCRP and IL6 vs the NN and DRM-I groups, and TNFα was increased in both DRM vs NN. DRM was characterised by increased oxidative stress, which was marked by a significant increase in ROS levels and a decrease in mitochondrial membrane potential in the DRM + I group. An evident reduction in mitochondrial oxygen consumption and glutathione concentration was observed in both DRM groups, and was accompanied by increased leukocyte adhesion and adhesion molecules and decreased rolling velocity in the DRM + I group. Furthermore, percentage of weight loss was negatively correlated with albumin, prealbumin, transferrin, O2 consumption, glutathione and leukocyte rolling velocity, and positively correlated with hsCRP, IL6, TNFα, ROS, leukocyte adhesion, and VCAM-1. Conclusions: Our results show that DRM is associated with oxidative stress and an inflammatory state, with a deterioration of endothelial dysfunction in the DRM + I population.
Article
Objective: To assess the efficacy and safety of N-acetylcysteine in the treatment of chronic pain. Methods: A systematic search was carried out until April 2020 for clinical studies of N-acetylcysteine in the management of any persistent or recurrent chronic pain condition for adults ≥ 18 years old. Risk of Bias was assessed using the validated risk of bias tools. When appropriate, a meta-analysis using a random-effects model was performed, with a fixed-effect model for sensitivity analysis. Results: Nine studies (n = 863) were included (5 randomized controlled trials [RCTs], 2 open-label non-comparative studies and 2 comparative studies), that evaluated patients with sickle cell disease (3), complex regional pain syndrome (1), pelvic pain/endometriosis (2), rheumatoid arthritis (1), diabetic neuropathy (1), and chronic neuropathic pain (1). In the pooled analysis of 3 RCTs, N-acetylcysteine did not reduce pain intensities (SMD -0.21, 95% CI -0.33 to 0.75, random-effects), improve functional outcomes (SMD 0.21, 95% CI -0.33 to 0.75) or quality of life (SMD 0.60, 95% CI -4.44 to 5.64); however, sensitivity analysis with a fixed effect model demonstrated an effect for pain intensities and function. Due to adverse events being inconsistently reported, no conclusion could be made regarding safety of N-acetylcysteine in chronic pain. Conclusions: While there is some evidence to indicate N-acetylcysteine may provide analgesic efficacy for certain pain conditions, there is insufficient evidence to provide definitive evidence on NAC in chronic pain management. Larger-size RCTs spanning a variety of chronic pain conditions are needed to determine N-acetylcysteine's role, if any, in pain medicine.
Article
Synoviocytes are located in the synovium lining layer, which is composed of macrophage-like synoviocytes (MLS) and fibroblast-like synoviocytes (FLS) with different characteristics. Mitochondria, which exist in most cells, are two membrane-covered organelles. In addition to providing the necessary ATP for synoviocytes, mitochondria are involved in the regulation of redox homeostasis and the integration of synoviocytes death signals. In recent years, mitochondrial dysfunction has been found in rheumatoid arthritis (RA) and osteoarthritis (OA). Interestingly, recent studies have started uncovering that mitochondria that were previously reported to play a role in chondrocytes or immune cells, but not known to have pronounced roles in synoviocytes, can actually play crucial roles in the regulation of the pathological properties of the synoviocytes. The purpose of this review is to summarize our current understanding of the key role of mitochondria in synoviocytes, including mitochondrial dysfunction in synoviocytes can induce and aggravate inflammatory responses and changes in mitochondrial structure and function with the involvement of multiple cytokines, signal pathway, and hypoxic state of synovial tissue alter the response of synoviocytes to apoptotic stimulation. Also, mitochondrial abnormalities in synoviocytes promote the synoviocytes invasion and proliferation.
Article
Full-text available
Folate is a nutrient essential for the development, function and regeneration of nervous systems. Folate deficiency has been linked to many neurological disorders including neural tube defects in fetus and Alzheimer's diseases in the elderly. However, the etiology underlying these folate deficiency-associated diseases is not completely understood. In this study, zebrafish transgenic lines with timing and duration-controllable folate deficiency were developed by ectopically overexpressing a recombinant EGFP-γ-glutamyl hydrolase (γGH). Impeded neural crest cell migration was observed in the transgenic embryos when folate deficiency was induced in early stages, leading to defective neural tube closure and hematopoiesis. Adding reduced folate or N-acetylcysteine reversed the phenotypic anomalies, supporting the causal link between the increased oxidative stress and the folate deficiency-induced abnormalities. When folate deficiency was induced in aged fish accumulation of beta-amyloid and phosphorylated Tau protein were found in the fish brain cryo-sections. Increased autophagy and accumulation of acidic autolysosome were apparent in folate deficient neuroblastoma cells, which were reversed by reduced folate or N-acetylcysteine supplementation. Decreased expression of cathepsin B, a lysosomal protease, was also observed in cells and tissue with folate deficiency. We concluded that folate deficiency-induced oxidative stress contributed to the folate deficiency-associated neuropathogenesis in both early and late stages of life.
Article
Full-text available
Shikonin is a quinone-containing natural product that induces the apoptotic death of some cancer cell lines in culture through increasing intracellular reactive oxygen species (ROS). Quinone-based drugs have shown potential in the clinic, making shikonin an interesting compound to study. Our previous study found that shikonin induces apoptosis in neuroblastoma by induction of ROS, but its mechanism of action and scope of activity are unknown. In this study, we investigated the mode of oxidative stress of shikonin in human glioma cells. ROS induction by shikonin was of mitochondrial origin, as demonstrated by detection of superoxide with MitoSOX Red. Pre-incubation of shikonin with inhibitors of different complexes of the respiratory chain suggested that shikonin-induced ROS production occurred via complex II. In addition, NADPH oxidase and lipooxygenase are two other main ROS-generated sites in shikonin treatment. ROS production by shikonin resulted in the inhibition of nuclear translocation of Nrf2. Stable overexpression of Nrf2 in glioma cells inhibited ROS generation by shikonin. ROS generation from mitochondrial complex II, NADPH oxidase and lipooxygenase is likely the primary mechanism by which shikonin induces apoptosis in glioma cells. These findings also have relevance to the development of certain ROS producers as anti-cancer agents. These, along with shikonin have potential as novel chemotherapeutic agents on human glioma.
Article
Full-text available
Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease whose etiology remains largely unknown. The uncontrolled oxidative stress in SLE contributes to functional oxidative modifications of cellular protein, lipid and DNA and consequences of oxidative modification play a crucial role in immunomodulation and trigger autoimmunity. Measurements of oxidative modified protein, lipid and DNA in biological samples from SLE patients may assist in the elucidation of the pathophysiological mechanisms of the oxidative stress-related damage, the prediction of disease prognosis and the selection of adequate treatment in the early stage of disease. Application of these biomarkers in disease may indicate the early effectiveness of the therapy. This review is intended to provide an overview of various reactive oxygen species (ROS) formed during the state of disease and their biomarkers linking with disease. The first part of the review presents biochemistry and pathophysiology of ROS and antioxidant system in disease. The second part of the review discusses the recent development of oxidative stress biomarkers that relates pathogenesis in SLE patients and animal model. Finally, this review also describes the reported clinical trials of antioxidant in the disease that have evaluated the efficacy of antioxidant in the management of disease with ongoing conventional therapy.
Article
Full-text available
Diet, particularly vitamin deficiency, is associated with the risk of birth defects. The aim of this review paper is to show the characteristics of common and severe neural-tube defects together with congenital heart defects (CHD) as vitamin deficiencies play a role in their origin. The findings of the Hungarian intervention (randomized double-blind and cohort controlled) trials indicated that periconceptional folic acid (FA)-containing multivitamin supplementation prevented the major proportion (about 90%) of neural-tube defects (NTD) as well as a certain proportion (about 40%) of congenital heart defects. Finally the benefits and drawbacks of three main practical applications of folic acid/multivitamin treatment such as (i) dietary intake; (ii) periconceptional supplementation; and (iii) flour fortification are discussed. The conclusion arrived at is indeed confirmation of Benjamin Franklin's statement: "An ounce of prevention is better than a pound of care".
Article
CONTEXT: It has been suggested that total blood homocysteine concentrations are associated with the risk of ischemic heart disease (IHD) and stroke. OBJECTIVE: To assess the relationship of homocysteine concentrations with vascular disease risk. DATA SOURCES: MEDLINE was searched for articles published from January 1966 to January 1999. Relevant studies were identified by systematic searches of the literature for all reported observational studies of associations between IHD or stroke risk and homocysteine concentrations. Additional studies were identified by a hand search of references of original articles or review articles and by personal communication with relevant investigators. STUDY SELECTION: Studies were included if they had data available by January 1999 on total blood homocysteine concentrations, sex, and age at event. Studies were excluded if they measured only blood concentrations of free homocysteine or of homocysteine after a methionine-loading test or if relevant clinical data were unavailable or incomplete. DATA EXTRACTION: Data from 30 prospective or retrospective studies involving a total of 5073 IHD events and 1113 stroke events were included in a meta-analysis of individual participant data, with allowance made for differences between studies, for confounding by known cardiovascular risk factors, and for regression dilution bias. Combined odds ratios (ORs) for the association of IHD and stroke with blood homocysteine concentrations were obtained by using conditional logistic regression. DATA SYNTHESIS: Stronger associations were observed in retrospective studies of homocysteine measured in blood collected after the onset of disease than in prospective studies among individuals who had no history of cardiovascular disease when blood was collected. After adjustment for known cardiovascular risk factors and regression dilution bias in the prospective studies, a 25% lower usual (corrected for regression dilution bias) homocysteine level (about 3 micromol/L [0.41 mg/L]) was associated with an 11% (OR, 0.89; 95% confidence interval [CI], 0.83-0.96) lower IHD risk and 19% (OR, 0.81; 95% CI, 0.69-0.95) lower stroke risk. CONCLUSIONS: This meta-analysis of observational studies suggests that elevated homocysteine is at most a modest independent predictor of IHD and stroke risk in healthy populations. Studies of the impact on disease risk of genetic variants that affect blood homocysteine concentrations will help determine whether homocysteine is causally related to vascular disease, as may large randomized trials of the effects on IHD and stroke of vitamin supplementation to lower blood homocysteine concentrations.
Article
Folate is a water-soluble B-vitamin and enzymatic cofactor that is necessary for the synthesis of purine and thymidine nucleotides and for the synthesis of methionine from homocysteine. Impairment of folate-mediated one-carbon metabolic pathways can result from B-vitamin deficiencies and/or single nucleotide polymorphisms, and increases risk for pathologies, including cancer and cardiovascular disease, and developmental anomalies including neural tube defects. Although several well validated metabolic and genomic biomarkers for folate deficiency exist, our understanding of the biochemical and genetic mechanisms whereby impaired folate metabolism increases risk for developmental anomalies and disease is limited, as are the mechanisms whereby elevated folate intake protects against these pathologies. Therefore, current initiatives to increase folate intakes in human populations to ameliorate developmental anomalies and prevent disease, while effective, lack predictive value with respect to unintended adverse outcomes.
Article
To detect the expression of cadherin-11 and its correlation with synovitis in osteoarthritis (OA), to explore the mechanism of over expression of cadherin-11 and its role in migratory or invasive capacity of fibroblast-like synoviocytes (FLS). Synovitis severity was recorded according to Krenn's scoring system in 25 osteoarthritis patients undergoing total knee arthroplasty. Cadherin-11 expression in OA synoviums and its correlation with synovitis score and systemic inflammation markers were explored. After induction with Interleukin-1 beta (IL-1β) or tumor necrosis factor-alpha (TNF-α),cadherin-11 expression on OA FLS was assessed by qPCR and western blot,the capacity of migration and invasion of OA FLS was tested by transwell assay, and matrix metalloproteinase-2 production was assessed with ELISA as cadherin-11 expression was up regulated after infection with cadherin-11 cDNA-containing lentivirus, also when cadherin-11 expression was knocked down after infection with cadherin 11 shRNA containing lentivirus. Cadherin-11 expression in OA synovium showed significant differences among different grades of synovitis. Cadherin-11 in the lining layer was positively correlated with hyperplasia of the lining layer, density of the resident cells, inflammatory infiltrate, total synovitis score and D-dimer. Cadherin-11 in the sublining layer was positively correlated with the density of the resident cells, inflammatory infiltrate, total synovitis score and erythrocyte sedimentation rate. IL-1β or TNF-α could up-regulate cadherin-11 expression on OA FLS at transcriptional and protein level. Over expression of cadherin-11 increased migratory or invasive capacity of OA FLS, while cadherin-11 knock down reduced migratory or invasive capacity and MMP-2 production in OA FLS. The over expression of cadherin-11 in osteoarthritis is positively correlated with synovitis severity, and can be driven by proinflammatory cytokines on OA FLS; cadherin-11 increases migratory or invasive capacity and MMP-2 production of fibroblast-like synoviocytes of osteoarthritis. Copyright © 2015. Published by Elsevier B.V.
Article
Oxidative stress and apoptosis were induced in neuronal cultures by inhibition of glutathione (GSH) biosynthesis with D,L-buthionine-S,R-sulfoximine (BSO). TRPM2 and TRPV1 cation channels are gated by oxidative stress. The oxidant effects of homocysteine (Hcy) may induce activation of TRPV1 and TRPM2 channels in aged mice as a model of Alzheimer's disease (AD). We tested the effects of Hcy, BSO and GSH on oxidative stress, apoptosis and Ca(2+) and influx via TRPM2 and TRPV1 channels in hippocampus of mice. Native mice hippocampus neurons were divided into 5 groups as follows; control, Hcy, BSO, Hcy+BSO and Hcy+BSO+GSH groups. The neurons in TRPM2 and TRPV1 experiments were stimulated by hydrogen peroxide and capsaicin, respectively. BSO and Hcy incubations increased intracellular free Ca(2+) concentrations, reactive oxygen species, apoptosis, mitochondrial depolarization, and levels of caspase 3 and 9. All of these increases were reduced by GSH treatments. Treatment with 2-aminoethyldiphenyl borate (2-APB) and N-(p-amylcinnamoyl)anthranilic acid (ACA) as potent inhibitors of TRPM2, capsazepine as a potent inhibitor of TRPV1, verapamil+diltiazem (V+D) as inhibitors of the voltage-gated Ca(2+) channels (VGCC) and MK-801 as a NMDA channel antagonist indicated that GSH depletion and Hcy elevation activated Ca(2+) entry into the neurons through TRPM2, TRPV1, VGCC and NMDA channels., Inhibitor roles of 2-APB and capsazepine on the Ca(2+) entry higher than in V+D and MK-801 antagonists. In conclusion, these findings support the idea that GSH depletion and Hcy elevation can have damaging effects on hippocampal neurons by perturbing calcium homeostasis, mainly through TRPM2 and TRPV1 channels. GSH treatment can partially reverse these effects.
Article
Interleukin-1β (IL-1β) upregulates intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expressions in osteoarthritis fibroblast-like synoviocytes (OA-FLS) via nuclear factor (NF)-κB-mediated mechanism; enhancement of leukocyte infiltration and upregulation of proinflammatory mediators play a crucial role in OA pathophysiology. MicroRNA (miR)-146a suppresses inflammatory responses by inhibiting NF-κB activity and target gene expression, and epigenetic mechanisms are reportedly involved in miR expression regulation. Here, we aimed to verify the inhibition of ICAM-1/VCAM-1 expression in OA-FLS on denbinobin treatment and to determine whether this inhibition was due to the miR-146a-dependent pathway. We also assessed the epigenetic regulation caused by histone acetyltransferases involved in denbinobin action. Denbinobin attenuated the upregulation of IL-1β-induced ICAM-1/VCAM-1 expression and monocyte adhesion to OA-FLS. The mechanism underlying the inhibitory effects of denbinobin involved miR-146a induction, which in turn inhibited NF-κB signaling. This is because miR-146a inhibitor abrogated the inhibitory effects of denbinobin. Furthermore, histone acetyltransferase inhibitor attenuated the denbinobin-induced upregulation of miR-146a expression and inhibited the acetylation of NF-κB-binding sites located within the miR-146a promoter region. These data suggest that an epigenetic mechanism plays a crucial role in the upregulation of miR-146a expression in response to denbinobin treatment. Our overall findings suggest that denbinobin can be used as a potent anti-inflammatory agent. Key message • Denbinobin inhibited IL-1β-induced ICAM-1/VCAM-1 expression and monocyte adhesion to OA-FLS. • It was due to denbinobin increased miR-146a level, which in turn inhibited NF-κB signaling. • Our overall findings suggest that denbinobin can be used as a potent anti-inflammatory agent.